A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine

NCT03960814 COMPLETED

This study will examine the influence of the basal insulins detemir and glargine on risk of cardiovascular death and death from all causes in patients treated by their general practitioner in United Kingdom (UK). The data for this study will be drawn from the Clinical Practice Research Datalink (CPRD) Register.

Details

Lead sponsor	Novo Nordisk A/S
Status	COMPLETED
Enrolment	12847
Start date	Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jun 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Diabetes Mellitus, Type 2

Interventions

• Insulin detemir

Countries

Denmark